Skip to main content
Clinical Trials/IRCT20161026030510N2
IRCT20161026030510N2
Recruiting
Phase 2

Investigation of Deep Brain Stimulation of Nucleus Accumbens for Treatment-Refractory Obsessive-Compulsive Disorder

Iran University of Medical Sciences0 sites5 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Iran University of Medical Sciences
Enrollment
5
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age: 16\-65
  • Diagnosis and Severity: Sever and chronic OCD for at least 5 years, Yale\-Brown scale at least 25, Hamilton scale at least 17, IQ more than 85
  • Treatment refractoriness: Not response for SSRI for 12 weeks, clomipramine 12 weeks, atypical antipsychotics for 6 weeks and CBT for 16 seasons

Exclusion Criteria

  • Psychotic disorders, bipolar disorder, autism disorder, substance abuse, epilepsy, dementia, Parkinson's disease and pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials